The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Zhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070 · cited 2×
“STATs are transcription factors activated in response to cytokines and growth factors (Zhong et al., 1994; Darnell 1997).”
BackgroundBowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743 · cited 5×
“Constitutive activation of Stat3 has also been demonstrated in breast carcinoma cells (Watson and Miller, 1995; Garcia et al., 1997; Bowman et al., 2000; Bromberg 2000; Page et al., 2000).”
BackgroundInfluentialCatlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J. L., Nuñez, G., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80011-4 · Cited by 1,638
Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., Leeder, J. S., Freedman, M., Cohen, A., Gazit, A., et al. (1996) · Nature · doi:10.1038/379645a0 · Cited by 897
Garcia, R., Bowman, T. L., Niu, G., Yu, H., Minton, S., Muro-Cacho, C. A., Cox, C. E., Falcone, R., Fairclough, R., Parsons, S., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204349 · Cited by 756
STAT proteins: novel molecular targets for cancer drug discovery
Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1204086 · Cited by 643
Epling-Burnette, P. K., Liu, J. H., Catlett-Falcone, R., Turkson, J., Oshiro, M., Kothapalli, R., Li, Y., Wang, J.-M., Yang-Yen, H.-F., Karras, J., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci9940 · Cited by 633 · cited 1×
“Moreover, blocking Stat3 signaling may also induce apoptosis independent of down regulation of Bcl-xL (Epling-Burnette et al., 2001; Niu et al., 2001).”
BackgroundBcl-X L interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation
Hu, Y., Benedict, M. A., Wu, D., Inohara, N., & Núñez, G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4386 · Cited by 529
Caspase-9, Bcl-XL, and Apaf-1 Form a Ternary Complex
Pan, G., O'Rourke, K., & Dixit, V. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.10.5841 · Cited by 521
Expression of bcl-xL can confer a multidrug resistance phenotype
Minn, A., Rudin, C., Boise, L., & Thompson, C. (1995) · Blood · doi:10.1182/blood.v86.5.1903.bloodjournal8651903 · Cited by 415 · cited 2×
“Further, dysregulation and imbalance of the Bcl-2 family of proteins has been shown to confer resistance to apoptosis induced by both physiological signals and chemotherapeutic drugs (Dole et al., 1995; Minn et al., 1995; Liu et al., 1998).”
BackgroundSTAT signaling in head and neck cancer
Song, J. I., & Grandis, J. R. (2000) · Oncogene · doi:10.1038/sj.onc.1203483 · Cited by 374
Caldenhoven, E., van Dijk, T. B., Solari, R., Armstrong, J., Raaijmakers, J. A. M., Lammers, J.-W. J., Koenderman, L., & de Groot, R. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.13221 · Cited by 373
Niu, G., Heller, R. F., Catlett-Falcone, R., Coppola, D., Jaroszeski, M. J., Dalton, W. S., Jove, R., & Yu, H. (1999) · PubMed · Cited by 363
Functional Roles of STAT Family Proteins: Lessons from Knockout Mice
Akira, S. (1999) · STEM CELLS · doi:10.1002/stem.170138 · Cited by 348
Roles of STAT3 defined by tissue-specific gene targeting
Akira, S. (2000) · Oncogene · doi:10.1038/sj.onc.1203478 · Cited by 344
Shen, Y., Devgan, G., Darnell, J. E., & Bromberg, J. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1543 · Cited by 249
Mechanism of STAT3 Activation by Insulin-like Growth Factor I Receptor
Zong, C. S., Chan, J., Levy, D. E., Horvath, C., Sadowski, H. B., & Wang, L.-H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000089200 · Cited by 240
Ni, Z., Lou, W., Leman, E. S., & Gao, A. C. (2000) · PubMed · Cited by 232
Watson, C., & Miller, W. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.162 · Cited by 226
Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.
Dole, M. G., Jasty, R., Cooper, M. J., Thompson, C. B., Núñez, G., & Castle, V. P. (1995) · PubMed · Cited by 214
Nielsen, M., Kæstel, C., Eriksen, K., Woetmann, A., Stokkedal, T., Kaltoft, K., Geisler, C., Röpke, C., & Ødum, N. (1999) · Leukemia · doi:10.1038/sj.leu.2401415 · Cited by 197
Constitutive Activation of Stat 3 Oncogene Product in Human Ovarian Carcinoma Cells
Huang, M., Page, C., Reynolds, R. K., & Lin, J. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5931 · Cited by 189
Self-citationSartor, C. I., Dziubinski, M. L., Yu, C., Jove, R., & Ethier, S. P. (1997) · PubMed · Cited by 184
Activation of Stat3 in v-Src-transformed Fibroblasts Requires Cooperation of Jak1 Kinase Activity
Zhang, Y., Turkson, J., Carter-Su, C., Smithgall, T., Levitzki, A., Kraker, A., Krolewski, J. J., Medveczky, P., & Jove, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002383200 · Cited by 164
Niu, G., Shain, K. H., Huang, M., Ravi, R. K., Bedi, A., Dalton, W. S., Jove, R., & Yu, H. (2001) · PubMed · Cited by 142
Self-citationBromberg, J. (2000) · Breast Cancer Research · doi:10.1186/bcr38 · Cited by 126
Wiener, J. R., Nakano, K., Kruzelock, R. P., Bucana, C. D., Bast, R. C., & Gallick, G. E. (1999) · PubMed · Cited by 95
Briscoe, J., Kohlhuber, F., & Müller, M. M. (1996) · Trends in Cell Biology · doi:10.1016/0962-8924(96)10028-3 · Cited by 92
Constitutive Activation of JAK1 in Src-transformed Cells
Campbell, G. S., Yu, C., Jove, R., & Carter‐Su, C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.5.2591 · Cited by 92
Bcl-xLIs Expressed in Ovarian Carcinoma and Modulates Chemotherapy-Induced Apoptosis
Liu, J. R., Fletcher, B., Page, C., Hu, C., Núñez, G., & Baker, V. V. (1998) · Gynecologic Oncology · doi:10.1006/gyno.1998.5125 · Cited by 85
Elevated phosphorylation of AKT and Stat3 in prostate, breast, and cervical cancer cells.
Page, C., Huang, M., Jin, X., Cho, K. R., Lilja, J., Reynolds, R. K., & Lin, J. (2000) · International Journal of Oncology · doi:10.3892/ijo.17.1.23 · Cited by 80
Self-citationActivity of pp60c-src in 60 different cell lines derived from human tumors.
Budde, R. J. A., Ke, S., & Levin, V. A. (1994) · PubMed · Cited by 76
Cited by
The biology of ovarian cancer: new opportunities for translation
Bast, R. C., Hennessy, B., & Mills, G. B. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2644 · Cited by 1,358
Ouyang, S., Li, H., Lou, L., Huang, Q., Zhang, Z., Mo, J., Li, M., Lu, J., Zhu, K., Chu, Y., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102317 · Cited by 507
Song, H., Wang, R., Wang, S., & Lin, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409894102 · Cited by 504
Self-citationSTAT3 as a target for inducing apoptosis in solid and hematological tumors
Al Zaid Siddiquee, K., & Turkson, J. (2008) · Cell Research · doi:10.1038/cr.2008.18 · Cited by 487
STAT3 Is Required for Proliferation and Maintenance of Multipotency in Glioblastoma Stem Cells
Sherry, M. M., Reeves, A., Wu, J. K., & Cochran, B. H. (2009) · Stem Cells · doi:10.1002/stem.185 · Cited by 478
Metadata
- Authors
- Burke, W. M., Jin, X., Lin, H.-J., Huang, M., Liu, R., Reynolds, R. K., & Lin, J.
- Venue
- Oncogene
- Published
- 2001-11-29
- Volume
- 20
- Issue
- 55
- Pages
- 7925-7934
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2004175299
- Cited by
- 269
- References
- 34
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.